Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DCL000264

Drug Information
NameXL765    
CompanyExelixis    
IndicationSolid tumours; non-small-cell lung cancer; malignant gliomasPhase I/II    
Therapeutic ClassAntineoplastic Agents    
ClinicalTrials.govNCT00777699;    
TargetPI3KInhibitor[1]
PI3KMultitarget[1]
Serine/threonine-protein kinase mTORInhibitor[1]
Serine/threonine-protein kinase mTORMultitarget[1]
Ref 1Pipeline of EXELIXIS. EXELIXIS. 2009 To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543